New England Capital Financial Advisors’s AbbVie ABBV Stock Holding History

New England Capital Financial Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$91.3K	Hold	363	–	–	0.02%	96
2026 Q1	$78.9K	Sell	363 -175	-33%	-$38.8K	0.02%	101
2025 Q4	$123K	Hold	538	–	–	0.05%	82
2025 Q3	$125K	Hold	538	–	–	0.05%	79
2025 Q2	$99.9K	Hold	538	–	–	0.05%	82
2025 Q1	$113K	Sell	538 -250	-32%	-$48.6K	0.06%	75
2024 Q4	$140K	Buy	788 +425	+117%	+$78.1K	0.07%	66
2024 Q3	$71.7K	Sell	363 -35	-9%	-$6.53K	0.04%	93
2024 Q2	$68.3K	Hold	398	–	–	0.04%	92
2024 Q1	$72.5K	Hold	398	–	–	0.04%	91
2023 Q4	$61.7K	Hold	398	–	–	0.04%	103
2023 Q3	$59.3K	Hold	398	–	–	0.04%	98
2023 Q2	$53.6K	Hold	398	–	–	0.04%	107
2023 Q1	$63.4K	Sell	398 -75	-16%	-$11.5K	0.04%	97
2022 Q4	$70.8K	Buy	+473	New	+$72.5K	0.05%	95

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

New England Capital Financial Advisors's ABBV Position: Q2 2026 in Review

New England Capital Financial Advisors held its AbbVie (ABBV) position steady in Q2 2026 at 363 shares worth $91.3K. The position accounts for 0.02% of the portfolio, ranked #96.

New England Capital Financial Advisors first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. The position peaked at $140K in Q4 2024. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

New England Capital Financial Advisors held 363 shares of AbbVie worth $91.3K as of Q2 2026.
New England Capital Financial Advisors left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.02% of New England Capital Financial Advisors's portfolio in Q2 2026, its #96 holding.
New England Capital Financial Advisors first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
New England Capital Financial Advisors's AbbVie position peaked at $140K in Q4 2024.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on New England Capital Financial Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.